This study not only provides theoretical support for the individualized administration of clopidogrel after PCI in clinical CHD patients, but also offers a new basis for CR risk in CHD patients and the change of AS process caused by ABCB1 gene polymorphism. The gene discussed is ABCB1; the disease is coronary artery disorder.